Research centre

Last updated on: 30/12/2013

1. Contact details{View data sources/studies associated with this centre}

Name of organisation

1) Department/Research groupPharmakovigilanzzentrum Embryonaltoxikologie

2) Organisation/affiliationCharité-Universitätsmedizin

Short Name in the inventoryEmbryotox Berlin

Website/Homepagewww.embryotox.de

Administrative Contact

Title Dr

Last name Schaefer

First name Christof

Address line 1Pharmakovigilanzzentrum Embryonaltoxikologie

Address line 2Spandauer Damm 130, Haus 10

Address line 3

CityBerlin

Postcode14050

CountryGermany

Phone number (incl. country code)49-30-30308119

Alternative phone number49-30-30308110

Fax number (incl. country code)49-30-30308122

Email address christof.schaefer@charite.de

Scientific Contact

Title Dr

Last name Schaefer

First name Christof

Address line 1Pharmakovigilanzzentrum Embryonaltoxikologie

Address line 2Spandauer Damm 130, Haus 10

Address line 3

CityBerlin

Postcode14050

CountryGermany

Phone number (incl. country code)49-30-30308119

Alternative phone number49-30-30308110

Fax number (incl. country code)49-30-30308122

Email address christof.schaefer@charite.de

2. Description

Embryotox Berlin was founded 1988 and provides information on drug risks to health care providers and pregnant women all over Germany. Through the consultation process, mainly via phone and email, all relevant data of the patient are collected by application of a structered questionnaire. Follow-up on pregnancy outcome until the infant's age of at least 6 weeks is recorded after birth. There are about 12,000 information requests per year, approximately 4,000 were followed-up. Patient data are stored in a special pharmacovigilance database adapted to the needs of pregnancy/newborn data. Pregnancy outcome data are evaluated in observational cohort studies using women without suspect drug exposure as controls. Several of these studies were published in peer reviewed journals. Our institute is independent from industry and financed by the city government, the BfArM and the federal health ministry. It belongs to the Charité-Universitätsmedizin since January1, 2012.